Colleen Lowry

450 total citations
10 papers, 338 citations indexed

About

Colleen Lowry is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Colleen Lowry has authored 10 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Colleen Lowry's work include Antifungal resistance and susceptibility (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pneumonia and Respiratory Infections (2 papers). Colleen Lowry is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pneumonia and Respiratory Infections (2 papers). Colleen Lowry collaborates with scholars based in United States. Colleen Lowry's co-authors include Lindsey R. Baden, Francisco M. Marty, Karen Fiumara, Malcolm Finkelman, David W. Kubiak, Corey Cutler, Joseph H. Antin, Aaron Deykin, Sara O. Vargas and Nimish Patel and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Biology of Blood and Marrow Transplantation.

In The Last Decade

Colleen Lowry

10 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colleen Lowry United States 8 227 197 40 37 32 10 338
E. Vidal Spain 8 91 0.4× 210 1.1× 31 0.8× 16 0.4× 53 1.7× 12 292
Gary Gartenberg United States 7 140 0.6× 118 0.6× 19 0.5× 11 0.3× 18 0.6× 11 270
Larry Nichols United States 8 111 0.5× 192 1.0× 31 0.8× 13 0.4× 54 1.7× 12 307
Junichiro Mera Japan 6 191 0.8× 191 1.0× 30 0.8× 6 0.2× 17 0.5× 7 316
Hosoon P. Dincsoy United States 11 115 0.5× 184 0.9× 23 0.6× 28 0.8× 108 3.4× 16 439
Elsa Tynell Sweden 11 105 0.5× 180 0.9× 14 0.3× 14 0.4× 42 1.3× 16 496
Anupama Chawla United States 11 97 0.4× 106 0.5× 26 0.7× 16 0.4× 131 4.1× 43 392
Raihan Rabbani Bangladesh 9 85 0.4× 73 0.4× 30 0.8× 14 0.4× 80 2.5× 46 316
Rawi Hazzan Israel 6 171 0.8× 96 0.5× 30 0.8× 11 0.3× 29 0.9× 17 316
Subhashini A. Sellers United States 6 136 0.6× 237 1.2× 18 0.5× 15 0.4× 18 0.6× 11 404

Countries citing papers authored by Colleen Lowry

Since Specialization
Citations

This map shows the geographic impact of Colleen Lowry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Lowry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Lowry more than expected).

Fields of papers citing papers by Colleen Lowry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Lowry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Lowry. The network helps show where Colleen Lowry may publish in the future.

Co-authorship network of co-authors of Colleen Lowry

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Lowry. A scholar is included among the top collaborators of Colleen Lowry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Lowry. Colleen Lowry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Patel, Nimish, et al.. (2021). Comparative effectiveness of early‐targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans’ affairs patients with infections due to Clostridioides difficile. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(2). 212–219. 7 indexed citations
3.
4.
Greenwood, Bonnie C., Paul M. Szumita, & Colleen Lowry. (2009). Pharmacist-Driven Aminoglycoside Quality Improvement Program. Journal of Chemotherapy. 21(1). 42–45. 7 indexed citations
5.
Lowry, Colleen, Francisco M. Marty, Sara O. Vargas, et al.. (2007). Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study. Transplant Infectious Disease. 9(2). 121–125. 61 indexed citations
6.
Marty, Francisco M., et al.. (2006). Reactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous Antimicrobials. Antimicrobial Agents and Chemotherapy. 50(10). 3450–3453. 115 indexed citations
7.
Marty, Francisco M., Colleen Lowry, Corey Cutler, et al.. (2006). Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(5). 552–559. 77 indexed citations
8.
Szumita, Paul M., et al.. (2006). Using the high-dose corticotropin test to diagnose relative adrenal insufficiency in vasopressor-dependent septic shock. American Journal of Health-System Pharmacy. 63(5). 466–471. 4 indexed citations
9.
Agarwal, Sandeep K., Agnes L. Maier, Lori B. Chibnik, et al.. (2005). Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center. Arthritis Care & Research. 53(6). 872–878. 42 indexed citations
10.
Lowry, Colleen, et al.. (2003). Evaluation of Personal Digital Assistant Drug Information Databases for the Managed Care Pharmacist. Journal of Managed Care Pharmacy. 9(5). 441–448. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Vidal Breakdown of academic impact, for papers by Gary Gartenberg Breakdown of academic impact, for papers by Larry Nichols Breakdown of academic impact, for papers by Junichiro Mera Breakdown of academic impact, for papers by Hosoon P. Dincsoy Breakdown of academic impact, for papers by Elsa Tynell Breakdown of academic impact, for papers by Anupama Chawla Breakdown of academic impact, for papers by Raihan Rabbani Breakdown of academic impact, for papers by Rawi Hazzan Breakdown of academic impact, for papers by Subhashini A. Sellers
Rankless by CCL
2026